Electromed (ELMD) EBT Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Electromed | 300.53 Mn | 283.55 Mn | 14.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,793.00 |
| Dec 31, 2025 | 296.00 |
| Sep 30, 2025 | 821.00 |
| Jun 30, 2025 | -63.00 |
| Mar 31, 2025 | 372.00 |
| Dec 31, 2024 | -219.00 |
| Sep 30, 2024 | -218.00 |
| Jun 30, 2024 | -85.00 |
| Mar 31, 2024 | 750.00 |
| Dec 31, 2023 | 860.00 |
| Sep 30, 2023 | -118.00 |
| Jun 30, 2023 | -515.00 |
| Mar 31, 2023 | 205.00 |
| Dec 31, 2022 | -8.00 |
| Sep 30, 2022 | -106.00 |
| Jun 30, 2022 | -1,627.00 |
| Mar 31, 2022 | -684.00 |
| Dec 31, 2021 | -64.00 |
| Sep 30, 2021 | 56.00 |
| Jun 30, 2021 | -233.00 |
| Mar 31, 2021 | -909.00 |
| Dec 31, 2020 | -289.00 |
| Sep 30, 2020 | -290.00 |
| Jun 30, 2020 | 1,145.00 |
| Mar 31, 2020 | 1,002.00 |
| Dec 31, 2019 | 1,011.00 |
| Sep 30, 2019 | 881.00 |
| Jun 30, 2019 | 1,028.00 |
| Mar 31, 2019 | 1,272.00 |
| Dec 31, 2018 | 1,801.00 |
| Sep 30, 2018 | 2,029.00 |
| Jun 30, 2018 | 2,805.00 |
| Mar 31, 2018 | 3,067.00 |
| Dec 31, 2017 | 2,711.00 |
| Sep 30, 2017 | 481.00 |
| Jun 30, 2017 | 2,529.00 |
| Mar 31, 2017 | 1,158.00 |
| Dec 31, 2016 | 1,002.00 |
| Sep 30, 2016 | -269.00 |
| Jun 30, 2016 | 178.00 |
| Mar 31, 2016 | -21.00 |
| Dec 31, 2015 | 921.00 |
| Sep 30, 2015 | 678.00 |